首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Drug metabolism and disposition

缩写:DRUG METAB DISPOS

ISSN:0090-9556

e-ISSN:1521-009X

IF/分区:4.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3840
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Hiroaki Takubo,Toshio Taniguchi,Yukihiro Nomura Hiroaki Takubo
Evaluation of the CYP3A induction risk is important in early drug development stages. This study focused on 4β-hydroxycholesterol (4β-HC) as an endogenous biomarker of drug-drug interactions (DDIs) caused by CYP3A induction. We investigat...
Shivam Ohri,Paarth Parekh,Lauren Nichols et al. Shivam Ohri et al.
Polypharmacy-related drug-drug interactions (DDIs) are a significant and growing healthcare concern. An increasing number of therapeutic drugs on the market underscores the necessity to accurately assess new drug combinations during pre-cli...
David Damoiseaux,Jos H Beijnen,Alwin D R Huitema et al. David Damoiseaux et al.
Early detection of drug-drug interactions (DDIs) can facilitate timely drug development decisions, prevent unnecessary restrictions on patient enrollment, resulting in clinical study populations that are not representative of the indicated ...
Laura M de Jong,Chandan Harpal,Dirk-Jan van den Berg et al. Laura M de Jong et al.
Compromised hepatic drug metabolism in response to proinflammatory cytokine release is primarily attributed to downregulation of cytochrome P450 (CYP) enzymes. However, whether inflammation also affects other phase I and phase II drug metab...
Brayden D Whitlock,Yingze Ma,Gwenaëlle Conseil et al. Brayden D Whitlock et al.
Millions of people globally are exposed to the proven human carcinogen arsenic at unacceptable levels in drinking water. In contrast, arsenic is a poor rodent carcinogen, requiring >100-fold higher doses for tumor induction, which may be ex...
Ulrike Glaenzel,Felix Huth,Fabian Eggimann et al. Ulrike Glaenzel et al.
Icenticaftor (QBW251) is a potentiator of the cystic fibrosis transmembrane conductance regulator protein and is currently in clinical development for the treatment of chronic obstructive pulmonary disease and chronic bronchitis. An absorpt...
Sandhya Subash,Bhagwat Prasad Sandhya Subash
Cytochrome P450 (CYP) superfamily represents the major drug-metabolizing enzymes responsible for metabolizing over 65% of therapeutic drugs, including those for pediatric use. CYP-ontogeny based physiologically based pharmacokinetic (PBPK) ...
Ryota Sakoda,Kan&#x;ichiro Ishiuchi,Tetsuhiro Yoshino et al. Ryota Sakoda et al.
Licorice is a crude drug that is used in traditional Japanese Kampo medicine and is also used as a sweetener. Occasionally, it causes pseudoaldosteronism (PsA) as a side effect. The major symptoms include hypokalemia, hypertension, edema, a...
Yuqing Wang,Jun Luo,Mengru Bai et al. Yuqing Wang et al.
Antifolates are important for chemotherapy in non-small cell lung cancer (NSCLC). They mainly rely on reduced folate carrier (RFC) and proton-coupled folate transporter (PCFT) to enter cells. PCFT is supposed to be the dominant transporter ...
Zeyu Guo,Jingjing Gao,Li Liu et al. Zeyu Guo et al.
Exercise significantly alters human physiological functions, such as increasing cardiac output and muscle blood flow and decreasing glomerular filtration rate (GFR) and liver blood flow, thereby altering the absorption, distribution, metabo...